
Metabolomics Market Size, Share, and Analysis, By Product and Service (Metabolomics Instruments, Separation Tools, and Detection Tools), By Application (Biomarker discovery, Drug Discovery, Personalized Medicine, Toxicology Testing, Nutrigenomics, Functi
Description
Metabolomics Market Size, Share, and Analysis, By Product and Service (Metabolomics Instruments, Separation Tools, and Detection Tools), By Application (Biomarker discovery, Drug Discovery, Personalized Medicine, Toxicology Testing, Nutrigenomics, Functional Genomics, Other Applications), By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Inborn Errors of Metabolism, Other), By End-User (Contract Research Organizations, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-users) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Metabolomics Market is anticipated to grow at a CAGR of 13.8%% in the forecast period (2024-2034), with the market size valued at USD 3 billion in 2023 and projected to reach USD 12.3 billion by 2034.
Metabolomics is the comprehensive study of metabolites, the small molecules involved in metabolic processes within a biological organism. This field focuses on analyzing and quantifying metabolic profiles to understand both normal and abnormal physiological conditions. By employing advanced techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, metabolomics provides insights into biomarker identification, pharmaceutical research, and personalized healthcare. It enables the detection of biochemical changes associated with diseases, facilitating early diagnosis and personalized treatment strategies. Additionally, metabolomics contributes to fields such as toxicology testing, nutrigenomics, and functional genomics by elucidating metabolic responses and interactions. Overall, metabolomics bridges the gap between genotype and phenotype, offering a comprehensive understanding of metabolic pathways and their implications for health and disease.
MARKET HIGHLIGHTS
Metabolomics Market is expected to reach $12.3 billion, with a growth rate of 13.8% during the forecast period. This growth is driven by the increasing importance of personalized medicine and precision health. The rising incidence of chronic diseases and the need for early and accurate diagnosis are major factors fueling the demand for comprehensive metabolic analysis. Technological advancements in mass spectrometry and NMR spectroscopy enhance data accuracy and analytical capabilities, further propelling market growth. Moreover, growing research activities and collaborations in the pharmaceutical and biotechnology sectors are boosting the market. The integration of metabolomics with genomics and proteomics is also expanding the applications in holistic health solutions, driving future market expansion.
Metabolomics Market Segments:
Growth Drivers
Rising Incidence of Chronic Diseases Boost Demand for Advanced Diagnostic Tools
Increasing R&D Investments in Drug Discovery to Boost Market Growth
Restraint
High Cost of Metabolomics Technologies to Restrict Growth and Development Opportunities
Key Players
PRODUCT OVERVIEW
Metabolomics Market is anticipated to grow at a CAGR of 13.8%% in the forecast period (2024-2034), with the market size valued at USD 3 billion in 2023 and projected to reach USD 12.3 billion by 2034.
Metabolomics is the comprehensive study of metabolites, the small molecules involved in metabolic processes within a biological organism. This field focuses on analyzing and quantifying metabolic profiles to understand both normal and abnormal physiological conditions. By employing advanced techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, metabolomics provides insights into biomarker identification, pharmaceutical research, and personalized healthcare. It enables the detection of biochemical changes associated with diseases, facilitating early diagnosis and personalized treatment strategies. Additionally, metabolomics contributes to fields such as toxicology testing, nutrigenomics, and functional genomics by elucidating metabolic responses and interactions. Overall, metabolomics bridges the gap between genotype and phenotype, offering a comprehensive understanding of metabolic pathways and their implications for health and disease.
MARKET HIGHLIGHTS
Metabolomics Market is expected to reach $12.3 billion, with a growth rate of 13.8% during the forecast period. This growth is driven by the increasing importance of personalized medicine and precision health. The rising incidence of chronic diseases and the need for early and accurate diagnosis are major factors fueling the demand for comprehensive metabolic analysis. Technological advancements in mass spectrometry and NMR spectroscopy enhance data accuracy and analytical capabilities, further propelling market growth. Moreover, growing research activities and collaborations in the pharmaceutical and biotechnology sectors are boosting the market. The integration of metabolomics with genomics and proteomics is also expanding the applications in holistic health solutions, driving future market expansion.
Metabolomics Market Segments:
- By Product and Services
- Metabolomics Instruments
- Separation Tools
- Detection Tools
- By Application
- Biomarker discovery
- Drug Discovery
- Personalized Medicine
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Other Applications
- By Indication
- Cancer
- Neurological Disorders
- Cardiovascular Diseases
- Inborn Errors of Metabolism
- Other
- By End User
- Contract Research Organizations
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End-users
Growth Drivers
Rising Incidence of Chronic Diseases Boost Demand for Advanced Diagnostic Tools
Increasing R&D Investments in Drug Discovery to Boost Market Growth
Restraint
High Cost of Metabolomics Technologies to Restrict Growth and Development Opportunities
Key Players
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
- Bruker Corporation
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Metabolon, Inc.
- Human Metabolome Technologies Inc.
- Shimadzu Corporation
- LECO Corporation
- Evotec SE
- Asuragen Inc.
- GeneBio
- Danaher Corporation
- Sciex (a Danaher Company)
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
573 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Metabolomics Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2. Metabolomics Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Metabolomics Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7. Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porters Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Metabolomics Market
- 10.1. Overview
- 10.2. Historical Analysis (2019-2022)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11. Metabolomics Market Size & Forecast 2024 A-2034 F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Product and Services
- 11.3.1.1. Metabolomics Instruments
- 11.3.1.1.1. By Value (USD Million) 2024-2034 F
- 11.3.1.1.2. Market Share (%) 2024-2034 F
- 11.3.1.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2. Separation Tools
- 11.3.1.2.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.2. Market Share (%) 2024-2034 F
- 11.3.1.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.3. Detection Tools
- 11.3.1.3.1. By Value (USD Million) 2024-2034 F
- 11.3.1.3.2. Market Share (%) 2024-2034 F
- 11.3.1.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2. By Application
- 11.3.2.1. Biomarker Discovery
- 11.3.2.1.1. By Value (USD Million) 2024-2034 F
- 11.3.2.1.2. Market Share (%) 2024-2034 F
- 11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.2. Drug Discovery
- 11.3.2.2.1. By Value (USD Million) 2024-2034 F
- 11.3.2.2.2. Market Share (%) 2024-2034 F
- 11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.3. Personalized Medicine
- 11.3.2.3.1. By Value (USD Million) 2024-2034 F
- 11.3.2.3.2. Market Share (%) 2024-2034 F
- 11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.4. Toxicology Testing
- 11.3.2.4.1. By Value (USD Million) 2024-2034 F
- 11.3.2.4.2. Market Share (%) 2024-2034 F
- 11.3.2.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.5. Nutrigenomics
- 11.3.2.5.1. By Value (USD Million) 2024-2034 F
- 11.3.2.5.2. Market Share (%) 2024-2034 F
- 11.3.2.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.6. Functional Genomics
- 11.3.2.6.1. By Value (USD Million) 2024-2034 F
- 11.3.2.6.2. Market Share (%) 2024-2034 F
- 11.3.2.6.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.7. Other Applications
- 11.3.2.7.1. By Value (USD Million) 2024-2034 F
- 11.3.2.7.2. Market Share (%) 2024-2034 F
- 11.3.2.7.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3. By Indication
- 11.3.3.1. Cancer
- 11.3.3.1.1. By Value (USD Million) 2024-2034 F
- 11.3.3.1.2. Market Share (%) 2024-2034 F
- 11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.2. Neurological Disorders
- 11.3.3.2.1. By Value (USD Million) 2024-2034 F
- 11.3.3.2.2. Market Share (%) 2024-2034 F
- 11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.3. Cardiovascular Diseases
- 11.3.3.3.1. By Value (USD Million) 2024-2034 F
- 11.3.3.3.2. Market Share (%) 2024-2034 F
- 11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.4. Inborn Errors of Metabolism
- 11.3.3.4.1. By Value (USD Million) 2024-2034 F
- 11.3.3.4.2. Market Share (%) 2024-2034 F
- 11.3.3.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.5. Other
- 11.3.3.5.1. By Value (USD Million) 2024-2034 F
- 11.3.3.5.2. Market Share (%) 2024-2034 F
- 11.3.3.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4. By End User
- 11.3.4.1. Contract Research Organization
- 11.3.4.1.1. By Value (USD Million) 2024-2034 F
- 11.3.4.1.2. Market Share (%) 2024-2034 F
- 11.3.4.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.2. Academic and Research Institutes
- 11.3.4.2.1. By Value (USD Million) 2024-2034 F
- 11.3.4.2.2. Market Share (%) 2024-2034 F
- 11.3.4.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.3. Pharmaceutical and Biotechnology Companies
- 11.3.4.3.1. By Value (USD Million) 2024-2034 F
- 11.3.4.3.2. Market Share (%) 2024-2034 F
- 11.3.4.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.4. Other End-users
- 11.3.4.4.1. By Value (USD Million) 2024-2034 F
- 11.3.4.4.2. Market Share (%) 2024-2034 F
- 11.3.4.4.3. Y-o-Y Growth (%) 2024-2034 F
- 12. North America Metabolomics Market Size & Forecast 2024 A-2034 F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product & Services
- 12.3.2. By Application
- 12.3.3. By Indication
- 12.3.4. By End User
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13. Europe Metabolomics Market Size & Forecast 2024 A-2034 F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product & Services
- 13.3.2. By Application
- 13.3.3. By Indication
- 13.3.4. By End User
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia-Pacific Metabolomics Market Size & Forecast 2024 A-2034 F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product & Services
- 14.3.2. By Application
- 14.3.3. By Indication
- 14.3.4. By End User
- 14.4. Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Metabolomics Market Size & Forecast 2024 A-2034 F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product & Services
- 15.3.2. By Application
- 15.3.3. By Indication
- 15.3.4. By End User
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Metabolomics Market Size & Forecast 2024 A-2034 F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product & Services
- 16.3.2. By Application
- 16.3.3. By Indication
- 16.3.4. By End User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2023
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1. Agilent Technologies Inc.
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Thermo Fisher Scientific Inc.
- 18.3. Waters Corporation
- 18.4. Bruker Corporation
- 18.5. Bio-Rad Laboratories, Inc.
- 18.6. PerkinElmer Inc.
- 18.7. Metabolon, Inc.
- 18.8. Human Metabolome Technologies Inc.
- 18.9. Shimadzu Corporation
- 18.10. LECO Corporation
- 18.11. Evotec SE
- 18.12. Asuragen Inc.
- 18.13. GeneBio
- 18.14. Danaher Corporation
- 18.15. Sciex (a Danaher Company)
- 18.16. Other Prominent Players
- 19. Appendix
- 20. Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.